Study of a Urethral Catheter Coated With Eluting Silver Salts (SUCCESS)
NCT ID: NCT00482547
Last Updated: 2017-02-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
1188 participants
INTERVENTIONAL
2007-06-30
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Trial for the Safety and Effectiveness of a Novel Antimicrobial-Coated Foley Catheter for Reduction of CAUTI.
NCT01681511
Clinical Study Evaluating Safety of a New Catheter for Urinary Intermittent Catheter in Healthy Volunteers
NCT01292941
Safety and Performance of a New Coating for Urinary Intermittent Catheters
NCT01800903
New Coating for Urinary Intermittent Catheters
NCT06985888
Evaluation of a New Catheter Coating Process for Urinary Catheters Used for Intermittent Catheterization.
NCT03684941
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Silver-coated catheter
Bard Hydrogel Silver Salts Coated Latex Urinary Catheter System
Hydrogel Silver Salts Coated Latex Urinary Catheter System
Silver-coated catheter
Silicone-coated catheter
Bard silicone elastomer coated latex catheter system
Bard silicone elastomer coated latex catheter system
Silicone-coated catheter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hydrogel Silver Salts Coated Latex Urinary Catheter System
Silver-coated catheter
Bard silicone elastomer coated latex catheter system
Silicone-coated catheter
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* life expectancy of 3 months or more
* expected to require a urinary catheter for at least 48 hours
Exclusion Criteria
* presence of a urinary tract device
* concurrent genitourinary tract infection
* recent indwelling urinary catheter
* requires use of a non-study urinary catheter
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
C. R. Bard
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark Rupp, MD
Role: PRINCIPAL_INVESTIGATOR
University of Nebraska
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Henry Ford Hospital
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BMD-6003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.